Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma

Table 3

Comparison of clinical characteristics between patients with high and low ezrin intensity.

Characteristic	High (3+); ()	Low (0–2+); ()	value
Median age (25th–75th), y	12.0 (3–15)	13.5 (11–16)	0.30
Sex			0.48
Male	14 (52%)	16 (62%)
Female	13 (48%)	10 (39%)
Race			0.69
White	21 (78%)	19 (73%)
Non-white	6 (22%)	7 (27%)
Primary site			1.00
Extremity	12 (44%)	11 (42%)
Pelvis	5 (19%)	6 (23%)
Chest	4 (15%)	4 (15%)
Paraspinal	1 (4%)	1 (4%)
Other	5 (19%)	4 (15%)
Primary site			0.91
Axial	16 (59%)	15 (58%)
Nonaxial	11 (41%)	11 (42%)
Primary site			0.68
Pelvic	5 (19%)	6 (23%)
Nonpelvic	22 (81%)	20 (77%)
Tumor size, cm ()			0.14
≤8	7 (39%)	3 (17%)
>8	11 (61%)	15 (83%)
Stage			0.81
Localized	20 (74%)	20 (77%)
Metastatic	7 (26%)	6 (23%)

Two-sided Wilcoxon rank sum test.
Two-sided Fisher Exact test.
Pearson Chi-Square test.
Totals percentages do not sum to 100% due to rounding.